Sign in
4

Changes in Ownership

PALVELLA THERAPEUTICS, INC. Filed Acc 0000899243-16-022948

SVP, Chief Development Officer bought 10,000 shares at an average $1.70 ($17,037)

From the SEC's structured data for this filing

Trades in this filing

Matis Louis · SVP, Chief Development Officer

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2016-06-13 Purchase : show line 1 in the form +2,085 $1.68 $3,503 2,085 D
2016-06-14 Purchase : show line 2 in the form +7,915 $1.71 $13,535 10,000 D
Open-market purchases · 10,000 sh · avg $1.70 · $17,037
Loading xslF345X03/doc4.xml…